List of Chapters/Sections(Table Of Content)
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Analysis from 2022 to 2027
1.5.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industry Impact
Chapter 2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Competition by Types, Applications, and Top Regions and Countries
2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) (Volume and Value) by Type
2.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption and Market Share by Type (2016-2021)
2.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue and Market Share by Type (2016-2021)
2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) (Volume and Value) by Application
2.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption and Market Share by Application (2016-2021)
2.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue and Market Share by Application (2016-2021)
2.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) (Volume and Value) by Regions
2.3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption and Market Share by Regions (2016-2021)
2.3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption by Regions (2016-2021)
4.2 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Consumption, Export, Import (2016-2021)
4.4 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Consumption, Export, Import (2016-2021)
4.8 Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Consumption, Export, Import (2016-2021)
4.10 South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Analysis
5.1 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption and Value Analysis
5.1.1 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Under COVID-19
5.2 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume by Types
5.3 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Structure by Application
5.4 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption by Top Countries
5.4.1 United States 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
5.4.2 Canada 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
5.4.3 Mexico 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
Chapter 6 East Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Analysis
6.1 East Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption and Value Analysis
6.1.1 East Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Under COVID-19
6.2 East Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume by Types
6.3 East Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Structure by Application
6.4 East Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption by Top Countries
6.4.1 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
6.4.2 Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
6.4.3 South Korea 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
Chapter 7 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Analysis
7.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption and Value Analysis
7.1.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Under COVID-19
7.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume by Types
7.3 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Structure by Application
7.4 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption by Top Countries
7.4.1 Germany 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
7.4.2 UK 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
7.4.3 France 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
7.4.4 Italy 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
7.4.5 Russia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
7.4.6 Spain 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
7.4.7 Netherlands 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
7.4.8 Switzerland 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
7.4.9 Poland 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
Chapter 8 South Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Analysis
8.1 South Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption and Value Analysis
8.1.1 South Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Under COVID-19
8.2 South Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume by Types
8.3 South Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Structure by Application
8.4 South Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption by Top Countries
8.4.1 India 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
8.4.2 Pakistan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
8.4.3 Bangladesh 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Analysis
9.1 Southeast Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption and Value Analysis
9.1.1 Southeast Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Under COVID-19
9.2 Southeast Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume by Types
9.3 Southeast Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Structure by Application
9.4 Southeast Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption by Top Countries
9.4.1 Indonesia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
9.4.2 Thailand 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
9.4.3 Singapore 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
9.4.4 Malaysia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
9.4.5 Philippines 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
9.4.6 Vietnam 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
9.4.7 Myanmar 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
Chapter 10 Middle East 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Analysis
10.1 Middle East 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption and Value Analysis
10.1.1 Middle East 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Under COVID-19
10.2 Middle East 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume by Types
10.3 Middle East 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Structure by Application
10.4 Middle East 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption by Top Countries
10.4.1 Turkey 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
10.4.3 Iran 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
10.4.5 Israel 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
10.4.6 Iraq 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
10.4.7 Qatar 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
10.4.8 Kuwait 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
10.4.9 Oman 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
Chapter 11 Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Analysis
11.1 Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption and Value Analysis
11.1.1 Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Under COVID-19
11.2 Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume by Types
11.3 Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Structure by Application
11.4 Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption by Top Countries
11.4.1 Nigeria 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
11.4.2 South Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
11.4.3 Egypt 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
11.4.4 Algeria 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
11.4.5 Morocco 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
Chapter 12 Oceania 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Analysis
12.1 Oceania 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption and Value Analysis
12.2 Oceania 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume by Types
12.3 Oceania 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Structure by Application
12.4 Oceania 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption by Top Countries
12.4.1 Australia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
12.4.2 New Zealand 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
Chapter 13 South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Analysis
13.1 South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption and Value Analysis
13.1.1 South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Under COVID-19
13.2 South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume by Types
13.3 South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Structure by Application
13.4 South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume by Major Countries
13.4.1 Brazil 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
13.4.2 Argentina 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
13.4.3 Columbia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
13.4.4 Chile 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
13.4.5 Venezuela 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
13.4.6 Peru 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
13.4.8 Ecuador 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Business
14.1 Pfizer
14.1.1 Pfizer Company Profile
14.1.2 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Specification
14.1.3 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Minhai Bio
14.2.1 Minhai Bio Company Profile
14.2.2 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Specification
14.2.3 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Kexing Bio
14.3.1 Kexing Bio Company Profile
14.3.2 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Specification
14.3.3 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Cansino Bio
14.4.1 Cansino Bio Company Profile
14.4.2 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Specification
14.4.3 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Lanzhou Biological Preparations Institute
14.5.1 Lanzhou Biological Preparations Institute Company Profile
14.5.2 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Specification
14.5.3 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Forecast (2022-2027)
15.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Value and Growth Rate Forecast (2022-2027)
15.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Forecast by Type (2022-2027)
15.3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Type (2022-2027)
15.3.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price Forecast by Type (2022-2027)
15.4 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Volume Forecast by Application (2022-2027)
15.5 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
